A study from South Korea showed that female patients who underwent cancer treatments in the afternoon had better outcomes than those who were treated in the morning. Their five-year mortality rate was reduced by 12.5 times.
Results of the “Temporal Anticancer Therapy” study were released by Kim Jae-kyung, Research Director of the Center for Mathematical and Computational Sciences at the Institute for Basic Science (IBS), and Professor of Mathematical Sciences at KAIST, and Professor Youngil Koh of the Department of Hematology and Oncology at Seoul National University Hospital (SNUH), on Dec. 15.
The study of 210 patients with diffuse large B-cell lymphoma (a type of leukemia) showed that females who received cancer treatments in the afternoon had better outcomes than those treated in the morning. Researchers noted that women’s white blood cell count was lower in the morning and higher in the afternoon; but men did not have this variation. Time of treatment did not affect the outcome of the male patients in the study….